A randomized prospective clinical trial of adjuvant C. parvum immunotherapy in 260 patients with clinically localized melanoma (Stage I): Prognostic factors analysis and preliminary results of immunotherayp
Charles M. Balch, Richard V. Smalley, Alfred A. Bartolucci, Debora Burns, Cary A. Presant, John R. DurantVolume:
49
Année:
1982
Langue:
english
Pages:
6
DOI:
10.1002/1097-0142(19820315)49:63.0.co;2-x
Fichier:
PDF, 548 KB
english, 1982